Evidence map›Paper›PMID 25671002›Full record

ReviewThe western journal of emergency medicine2015

Anticoagulation drug therapy: a review.

Katherine Harter, Michael Levine, Sean O Henderson

Open access · goldAbstract readReview
In one paragraph

Review in The western journal of emergency medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed, 4 pooled it
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

94 citing papers in PubMed, 4 syntheses or guidelines pooled it, 255 citations in OpenAlex.

  1. Effectiveness and safety of edoxabanFrontiers in pharmacology · 2023
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Review
  10. Problems associated with the ATC system of drug classification.Naunyn-Schmiedeberg's archives of pharmacology · 2026
    Article
  11. Identification and treatment results for fracture-related infections following operative repair of a rotational ankle fractures.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2026
    Article
  12. Article
  13. [Anticoagulation in the setting of skin surgery].Dermatologie (Heidelberg, Germany) · 2025
    Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Katherine HarterUniversity of Southern California, LA+USC Medical Center, Department of Emergency Medicine, Los Angeles, California.
Michael LevineUniversity of Southern California, LA+USC Medical Center, Department of Emergency Medicine, Los Angeles, California.
Sean O HendersonUniversity of Southern California, LA+USC Medical Center, Department of Emergency Medicine, Los Angeles, California.
LAC+USC Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Historically, most patients who required parenteral anticoagulation received heparin, whereas those patients requiring oral anticoagulation received warfarin. Due to the narrow therapeutic index and need for frequent laboratory monitoring associated with warfarin, there has been a desire to develop newer, more effective anticoagulants. Consequently, in recent years many novel anticoagulants have been developed. The emergency physician may institute anticoagulation therapy in the short term (e.g. heparin) for a patient being admitted, or may start a novel anticoagulation for a patient being discharged. Similarly, a patient on a novel anticoagulant may present to the emergency department due to a hemorrhagic complication. Consequently, the emergency physician should be familiar with the newer and older anticoagulants. This review emphasizes the indication, mechanism of action, adverse effects, and potential reversal strategies for various anticoagulants that the emergency physician will likely encounter.

Indexed as

Emergency Service, HospitalAnticoagulantsAntithrombinsEmbolismFactor Xa InhibitorsFibrinolytic AgentsHemorrhageHeparinHumansThrombosisWarfarinAnticoagulantsAntithrombinsFactor Xa InhibitorsFibrinolytic AgentsHeparinWarfarin

Identifiers

PMID25671002
PMCPMC4307693
OpenAlexW2149588263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.